Lourdes Rodríguez‐Fragoso

Universidad Autónoma del Estado de Morelos — Mexico

Medicine · Health Sciences

17h-index1.3kcitations124works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(23), Liver physiology and pathology(15), Nanoparticles: synthesis and applications(11), Metabolism and Genetic Disorders(10), Quantum Dots Synthesis And Properties(9)

Publications124 total

Amphotericin-A21 Induces Antineoplastic Effects through the Modulation of Apoptosis in Human Tumoral Cells
Pharmacology·2025Open Access
A Promising Amphotericin B Derivative Induces Morphological Alterations, Mitochondrial Damage, and Oxidative Stress In Vitro and Prevents Mice from Death Produced by a Virulent Strain of Trypanosoma cruzi
Microorganisms·2024· 7 citedOpen Access
Amphotericin-A21 produces antiproliferative effects through modulating EGFR expression in glioblastoma multiforme cells
Journal of Pharmacology and Experimental Therapeutics·2024
Cellular uptake of dextrin capped cadmium sulfide quantum dots with platelets and its related effect on hemostasis function
Journal of Pharmacology and Experimental Therapeutics·2024
Toxicity of Quantum Dots
IntechOpen eBooks·2024· 1 citedOpen Access
Synthesis, characterization, and pharmacological evaluation of dextrin capped cadmium sulfide quantum dots conjugated with temozolomide for drug delivery and imaging application
World Journal of Advanced Science and Technology·2023Open Access
EGF-receptor phosphorylation and downstream signaling are activated by genistein during subacute liver damage
Journal of Molecular Histology·2023· 2 citedOpen Access
Gallic acid modifies EGFR phosphorylation in rat with hepatic preneoplasia
Journal of Pharmacology and Experimental Therapeutics·2023Open Access
Amphotericin A21 reduces cell proliferation and modulates anti- and pro-apoptotic proteins in MCF-7 cells.
Journal of Pharmacology and Experimental Therapeutics·2023Open Access
Beta-hydroxyphosphocarnitine modifies the inflammation in rats with non-alcoholic steatohepatitis
Journal of Pharmacology and Experimental Therapeutics·2023Open Access
Synthesis, Characterization and Biocompatibility of Maltodextrin-coated Cadmium Sulfide Quantum Dots in Experimental Models
2023
β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats
BMC Pharmacology and Toxicology·2022· 1 citedOpen Access
Models of Hepatotoxicity for the Study of Chronic Liver Disease
IntechOpen eBooks·2022· 1 citedOpen Access
Polyene Antibiotics Physical Chemistry and Their Effect on Lipid Membranes; Impacting Biological Processes and Medical Applications
Membranes·2022· 44 citedOpen Access
Pharmacological Evaluation of Beta‐Hydroxifosphocarnitine in No‐Alcoholic Esteatohepatitis Induced in Rats
The FASEB Journal·2022
Amphotericin A21 Induces Cytotoxic Effects in Breast Cancer Cell Lines
The FASEB Journal·2022· 1 cited
Advances in Graphene Platforms for Drug Delivery in Cancer and Its Biocompatibility
IntechOpen eBooks·2022Open Access
A Brief Note on Dieting
HAL (Le Centre pour la Communication Scientifique Directe)·2022
Common Way of Making an Eating Regimen Rendition of a Food Generally
HAL (Le Centre pour la Communication Scientifique Directe)·2022
Pharmacological Evaluation of Beta‐Hydroxifosphocarnitine in No‐Alcoholic Steatohepatitis Induced in Rats
The FASEB Journal·2021
page 1 of 7Next →

Frequent Co-authors

Jorge Reyes‐Esparza(33), P. Rodríguez-Fragoso(7), Angel León‐Buitimea(5), Anahí Rodríguez‐López(5), Miguel Á. Duarte‐Vázquez(5), Scott W. Burchiel(4), Ulises Osuna‐Martínez(4), Mario Fernández‐Zertuche(4), G. González de la Cruz(4), Rocio Gómez‐Cansino(4), Brissa Mendoza‐Rivera(4), Iván Ortega‐Blake(3), G. Farina(3), Ivonne Gutiérrez‐Sancha(3), Ricardo De la Cruz‐Cordero(3), Antonieta Gómez‐Solís(3), Janet Sánchez-Quevedo(3), Dea Herrera‐Ruiz(2), Eliseo Torres(2), Jorge Luis Poo(2)